Skip to content

MR-guided Focused Ultrasound Surgery of ductal carcinoma in situ: Therapeutic effect and safety

MR-guided Focused Ultrasound Surgery of ductal carcinoma in situ: Therapeutic effect and safety - MR-guided Focused Ultrasound Surgery of ductal carcinoma in situ: Therapeutic effect and safety

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030255
Enrollment
10
Registered
2017-12-11
Start date
2017-12-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ductal carcinoma in situ

Interventions

MRI guided focused ultrasound treatment

Sponsors

Showa university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1 Women 18 years and older with DCIS less than 2 cm in diameter 2 Patients signed an informed consent form before participating in this study. 3 Patient who can get an MRI

Exclusion criteria

Exclusion criteria: 1 Metallic implants or other incompatibility with MRI 2 Pregnant or lactating patients 3 Patients not to endure this treatment 4 Patients who are'nt eligible for this study by other reasons

Design outcomes

Primary

MeasureTime frame
Completely coagulation necrosis of tumor using histopathological methods.

Secondary

MeasureTime frame
1 adverse events 2 cosmetically assessment 3 the amount of cfDNA in plasma before and after treatment 4 non palpable lesion become palpable post treatment 5 negative margin of surgical specimen 6 no residual cancer cell in biopsy specimen before treatment

Countries

Japan

Contacts

Public ContactAkiko Matsutani

Showa university Breast surgery

am24791319@gmail.com03-3784-8000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026